Vivesto AB - Asset Resilience Ratio

Latest as of March 2026: 17.16%

Vivesto AB (VIVE) has an Asset Resilience Ratio of 17.16% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Vivesto AB current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr30.51 Million

≈ $3.28 Million USD Cash + Short-term Investments

Total Assets

Skr177.85 Million

≈ $19.14 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Vivesto AB's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Vivesto AB assets under control.

Liquid Assets Composition Over Time

This chart breaks down Vivesto AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Vivesto AB (VIVE) financial obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr30.51 Million	17.16%
Total Liquid Assets	Skr30.51 Million	17.16%

Asset Resilience Insights

Good Liquidity Position: Vivesto AB maintains a healthy 17.16% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Vivesto AB Industry Peers by Asset Resilience Ratio

Compare Vivesto AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Vivesto AB (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Vivesto AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.05%	Skr72.00K ≈ $7.75K	Skr149.04 Million ≈ $16.04 Million	-18.18pp
2024-12-31	18.23%	Skr31.51 Million ≈ $3.39 Million	Skr172.88 Million ≈ $18.60 Million	-14.74pp
2023-12-31	32.97%	Skr72.75 Million ≈ $7.83 Million	Skr220.67 Million ≈ $23.75 Million	-4.42pp
2022-12-31	37.39%	Skr133.05 Million ≈ $14.32 Million	Skr355.88 Million ≈ $38.30 Million	+22.35pp
2021-12-31	15.04%	Skr89.36 Million ≈ $9.62 Million	Skr594.31 Million ≈ $63.96 Million	-13.60pp
2020-12-31	28.64%	Skr247.28 Million ≈ $26.61 Million	Skr863.54 Million ≈ $92.93 Million	+5.35pp
2019-12-31	23.28%	Skr234.08 Million ≈ $25.19 Million	Skr1.01 Billion ≈ $108.19 Million	+23.28pp
2018-12-31	0.00%	Skr1.00 ≈ $0.11	Skr646.38 Million ≈ $69.56 Million	-3.88pp
2015-12-31	3.88%	Skr20.01 Million ≈ $2.15 Million	Skr515.58 Million ≈ $55.48 Million	-5.87pp
2014-12-31	9.75%	Skr50.15 Million ≈ $5.40 Million	Skr514.57 Million ≈ $55.38 Million	--

pp = percentage points

About Vivesto AB

ST:VIVE Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$10.85 Million

Skr100.86 Million SEK

Market Cap Rank

#26944 Global

#579 in Sweden

Share Price

Skr9.11

Change (1 day)

-2.04%

52-Week Range

Skr0.08 - Skr17.00

All Time High

Skr17.00